Compare CALY & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CALY | ITGR |
|---|---|---|
| Founded | 1982 | 1970 |
| Country | United States | United States |
| Employees | 28000 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.1B |
| IPO Year | N/A | 2000 |
| Metric | CALY | ITGR |
|---|---|---|
| Price | $18.40 | $93.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $16.50 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 2.4M | 424.4K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $9.70 | $1.69 |
| Revenue Next Year | $3.01 | $6.53 |
| P/E Ratio | ★ $64.24 | $191.56 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $12.26 | $62.00 |
| 52 Week High | $19.36 | $120.41 |
| Indicator | CALY | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 61.64 | 55.89 |
| Support Level | $14.20 | $82.58 |
| Resistance Level | $19.36 | $95.48 |
| Average True Range (ATR) | 0.53 | 2.60 |
| MACD | -0.10 | -0.09 |
| Stochastic Oscillator | 49.73 | 73.19 |
Callaway Golf Co is a golf equipment, gear and apparel company with a portfolio of world-wide brands, including Callaway Golf, Odyssey, TravisMathew, and OGIO. Callaway designs, manufactures, and sells high-performance golf clubs, golf balls, apparel, bags, and other accessories-setting the standard for performance in the game of golf. The company has two operating and reportable business segments: Golf Equipment and Apparel, Gear and Other. Geographically, the company operates in United States, Europe, Asia, and Rest of World, of which it derives maximum revenue from United States.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.